Multiple Sclerosis Centers of Excellence
MS Veteran Newsletter
Discusses symptom management, medications, and living well with MS. Check out our latest issue!
Get Out and Play!
Exercising is fun, will decrease your stress, reduce weight, improve your endurance, decrease depression, and reduce secondary medical conditions.
MSCoE Veteran YouTube Videos
View our short videos that highlight the life of a Veteran living with MS. Videos cover a variety of topics.
Multiple Sclerosis Centers of Excellence
The Multiple Sclerosis Centers of Excellence (MSCoE) are dedicated to furthering the understanding of multiple sclerosis (MS), its impact on Veterans, and effective treatments to help manage MS. By partnering with Veterans, caregivers, health care professionals, MS advocates, Veteran service organizations, and community health care institutes, MSCoE strives to minimize impairment and maximize quality of life for Veterans with MS.
MSCoE East and West have developed a national network of MS Regional Programs and MS Support Programs within the VA.
Given the size of the population of Veterans with MS seeking treatment in VA and their distribution across the country, it is feasible to provide access to high quality subspecialty care through a hub and spoke network with designated MS Regional Programs supporting local facilities.
Each Veterans Integrated Service Network (VISN) will have at least one MS Regional Program that will serve as a source for MS specialty consultation and education.
May 25, 2020 - Memorial Day
Our country has been blessed with men and women whose sacrifices allowed us to flourish as individuals, as a society, and as a Nation. On Memorial Day, we pause to remember, honor, and express our gratitude to all those Americans who lost their lives in uniform.
MSCoE staff and associates authored four articles for the April 2020 issue of Federal Practitioner.
Chris W. Hollen, MD, M. Mateo Paz Soldán, MD, PhD, John R. Rinker, II, MD and Rebecca I. Spain, MD, MSPH. The Future of Progressive MS Therapies. Fed Pract. 2020 Apr;37(Suppl 1):S43-S49. (full article)
Michelle H. Cameron, MD, PT, MCR, Jodie K. Haselkorn, MD, MPH and Mitchell T. Wallin, MD, MPH. The MS Centers of Excellence: A Model of Excellence in the VA. Fed Pract. 2020 Apr; 37(Suppl 1): S6–S10. (full article)
Mitchell T. Wallin, MD, MPH, Ruth Whitham, MD, Heidi Maloni, PhD, Shan Jin, PhD, Jonathan Duckart, Jodie Haselkorn, MD, MPH and William J. Culpepper, PhD. The MS Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration. Fed Pract. 2020 Apr; 37(Suppl 1): S18–S23. (full article)
Kathryn Tortorice, PharmD, BCPS and Natasha Antonovich, PharmD, BCPS. MS Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System. Fed Pract. 2020 Apr; 37(Suppl 1): S36–S42. (full article)
If you push a manual wheelchair or use other types of assistive technology (AT), there are unique precautions you should take related to hand washing. COVID-19 can survive on the surfaces of your wheelchair or AT which you come in frequent contact with, such as the handrims. Any virus that might be on your hands is transferred to your handrims as you push your wheelchair. Guidance on protecting yourself and your loved ones can be found within the following PDF.
Veterans with MS, families, and MS health care professionals have questions regarding MS and COVID19. The MS Centers of Excellence are watching the situation closely and support the guidance from VA Central Office (VACO COVID19), the Centers for Disease Control (CDC COVID19), and the National MS Society (NMSS COVID19). Please follow these links for the latest information.
At this time, Veterans with MS are not known to be at increased risk of COVID-19 per se, and general precautions should be taken by all Veterans with MS, their families, and their providers. Follow your facility guidance on inpatient and outpatient procedures. We encourage the use of telehealth and/or phone call visits in place of in-person visits when possible.
The more immunosuppressive MS disease-modifying therapies (DMT) including ocrelizumab, rituximab, alemtuzumab, and cladribine may carry a higher risks regarding COVID19. The decision to start, continue, delay dosing, or stop those DMTs should be decided on a case by case basis always considering factors of age, medical comorbidities, disability, etc.
Links are provided as a convenience and for informational purposes only. They do not constitute an endorsement or an approval by MSCoE of any of the products, services, or opinions of the organization. MSCoE bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.
VA MS Publications
The VA ranks as one of the nation’s leaders in health research. Thousands of studies are conducted at VA medical centers, outpatient clinics, and nursing homes each year. This research has significantly contributed to advancements in health care for Veterans and other Americans from every walk of life.
Recent VA Provider Publications
Disclaimer: Links are provided as a convenience and for informational purposes only. They do not constitute an endorsement or an approval by MSCoE of any of the products, services, or opinions of the organization. MSCoE bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.
We are fortunate to have Veterans share their stories of living with MS. These stories are filled with life's challenges, the value of family and friends, lots of hopefulness, with a little sense of humor thrown in. We hope you will enjoy reading these stories and in a small way feel connected to others that are living with this disease.
Our YouTube series covers a variety issues effecting Veterans with MS. Each video shares perspectives from Veterans and their health care team.